Learn about PhenoVista’s unique service offerings and how expertise in developing complex, in vitro studies to provide actionable and relevant data can help drive drug discovery forward.
This webinar, led by Dr. Ana Wang, focuses on advanced techniques in drug discovery. It features an exploration of custom assays that incorporate complex 3D cell cultures and co-cultures of multiple cell types, which closely mimic biological phenomena. Additionally, we discuss cell painting—an innovative technique that enhances target identification and compound optimization through comprehensive phenotypic profiling.
Dr. Wang also highlights PhenoVista’s Ready-2-Go (R2G) assays—a suite of predefined services that offer the quickest turnaround and span myriad disease areas, including fibrosis, neurobiology, oncology, and cell and gene therapy.
Key Topics Include:
- An overview of the diverse types of service offerings at PhenoVista: Ready-2-Go, Custom, Cell Painting, and Imaging & Analysis assay services
- Techniques for modeling complex biology to create reliable, scalable assays with an emphasis on high-content imaging to de-risk go/no-go decisions in the drug-development process
- Application of assays across various disease areas like neurobiology, fibrosis, oncology, and cell and gene therapy.
- Learn how to use the digital storefront to get a project with PhenoVista started
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Product Manager
PhenoVista Biosciences
Dr. Ana Wang is the Product Manager at PhenoVista Biosciences. She received her B.Sc. in chemistry with a specialization in biochemistry at the University of Virginia in Charlottesville, VA and her Ph.D. from Scripps Research in La Jolla, CA.
Production Partner
PhenoVista Biosciences
PhenoVista is a leader in the development and implementation of multiplexed, high-content, imaging-based, phenotypic assays for biopharmaceutical clients. Clients gain access to novel insights related to the complex biology underlying target validation, therapeutic delivery, efficacy and safety, cytotoxicity, and mechanisms of action.
Related Content
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.